Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Contraception. 2012 Nov 12;88(1):74–82. doi: 10.1016/j.contraception.2012.10.004

Table 1.

Demographics, fertility, health, and contraceptive characteristics of discordant couples eligible for LARC in Kigali, Rwanda (August 6, 2009 to December 15, 2010) and Lusaka, Zambia (July 9, 2009 to December 18, 2010)

Kigali, Rwanda Lusaka, Zambia
Total
(N=365)
IUD (N=30) Implant
(N=100)
No LARC
(N=235)
p-
value
Total
(N=528)
IUD
(N=38)
Implant
(N=139)
No LARC
(N=351)
p-
value
Questionnaire
administered to:
N % N % N % N % 0.63 N % N % N % N % 0.38
 Woman alone 111 30.4 7 6.3 30 27.0 74 66.7 333 63.1 21 6.3 93 27.9 219 65.8
 Couple 254 69.6 23 9.1 70 27.6 161 63.4 195 36.9 17 8.7 46 23.6 132 67.7
Couple’s HIV serostatus
at baseline
0.05* 0.79
 Discordant (man is HIV
 positive)
166 45.5 17 10.2 36 21.7 113 68.1 242 45.8 18 7.4 67 27.7 157 64.9
 Discordant (woman is
HIV positive)
199 54.5 13 6.5 64 32.2 122 61.3 286 54.2 20 7.0 72 25.2 194 67.8
HIV-positive partner on
antiretroviral therapy
0.25 0.77
 Yes 79 21.6 3 3.8 21 26.6 55 69.6 86 16.3 6 7.0 20 23.3 60 69.8
 No 286 78.4 27 9.4 79 27.6 180 62.9 442 83.7 32 7.2 119 26.9 291 65.8
Reproductive intentions 0.68 0.52
 Want a child in ≥3 years 25 6.8 2 8.0 5 20.0 18 72.0 83 15.7 4 4.8 25 30.1 54 65.1
 Do not want more
 children
340 93.2 28 8.2 95 27.9 217 63.8 445 84.3 34 7.6 114 25.6 297 66.7
Current contraceptive
method
0.41 0.60
Condoms only 289 79.2 25 8.7 72 24.9 192 66.4 414 78.4 33 8.0 114 27.5 267 64.5
Injectables 65 17.8 5 7.7 23 35.4 37 56.9 51 9.7 2 3.9 10 19.6 39 76.5
Oral contraceptives 11 3.0 0 0.0 5 45.5 6 54.5 63 11.9 3 4.8 15 23.8 45 71.4
Women age, mean (SD) 29.2 6.1 29.6 5.8 27.5 5.4 30.0 6.3 0.003* 29.7 6.3 29.6 6.7 28.6 6.0 30.1 6.4 0.06
Men age, mean (SD) 34.8 7.9 34.8 8.1 34.0 8.3 35.1 7.7 0.49 36.0 7.5 35.3 8.2 35.2 7.7 36.4 7.3 0.24
Number of previous
pregnancies, mean (SD)
3.0 2.0 2.8 2.0 2.7 1.8 3.2 2.1 0.10 3.7 2.1 3.8 2.2 3.5 2.1 3.8 2.1 0.48
*

Statistically significant (p<0.05) with “No LARC” as the reference group.